Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott Kinlay

Circulation

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Circulation|February 28, 2014
Coronary artery spasm as a cause of anginaScott Kinlay
Circulation|March 20, 2013
Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery diseaseScott Kinlay
Circulation|September 5, 2015
Does this study make my aorta look fat?Scott Kinlay
Circulation|May 25, 2011
Fire in the hole: carotid stenting versus endarterectomyScott Kinlay
Circulation|November 9, 2011
Changes in stroke epidemiology, prevention, and treatmentScott Kinlay
Circulation|June 22, 2016
The Future of Vascular Biology and MedicineScott Kinlay, Thomas Michel, Jane A Leopold
Circulation|July 21, 2004
Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) StudyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
Circulation|September 17, 2003
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL studyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
Circulation|December 4, 2002
Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cellsUwe Schönbeck, Norbert Gerdes, Nerea Varo, et al.
Circulation|October 6, 2005
Characterization of human atherosclerotic plaques by intravascular magnetic resonance imagingEric Larose, Yerem Yeghiazarians, Peter Libby, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Circulation|February 28, 2014
Coronary artery spasm as a cause of anginaScott Kinlay
Circulation|March 20, 2013
Outcomes for clinical studies assessing drug and revascularization therapies for claudication and critical limb ischemia in peripheral artery diseaseScott Kinlay
Circulation|September 5, 2015
Does this study make my aorta look fat?Scott Kinlay
Circulation|May 25, 2011
Fire in the hole: carotid stenting versus endarterectomyScott Kinlay
Circulation|November 9, 2011
Changes in stroke epidemiology, prevention, and treatmentScott Kinlay
Circulation|June 22, 2016
The Future of Vascular Biology and MedicineScott Kinlay, Thomas Michel, Jane A Leopold
Circulation|July 21, 2004
Effect of atorvastatin on risk of recurrent cardiovascular events after an acute coronary syndrome associated with high soluble CD40 ligand in the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) StudyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
Circulation|September 17, 2003
High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL studyScott Kinlay, Gregory G Schwartz, Anders G Olsson, et al.
Circulation|December 4, 2002
Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cellsUwe Schönbeck, Norbert Gerdes, Nerea Varo, et al.
Circulation|October 6, 2005
Characterization of human atherosclerotic plaques by intravascular magnetic resonance imagingEric Larose, Yerem Yeghiazarians, Peter Libby, et al.
Pageof 2